Earnings roundup: Merck, Lilly, Vertex

Merck & Co. Inc. (NYSE:MRK), Eli Lilly and Co. (NYSE:LLY) and Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) all reported 3Q16 earnings and corporate updates on Tuesday.

Merck raised its full-year 2016 guidance of adjusted EPS to $3.71-$3.78 from $3.67-$3.77. The company posted 3Q16 adjusted EPS

Read the full 439 word article

User Sign In